Cargando…
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy
(R-)miniCHOP therapy, which delivers approximately half-doses of the (R-)CHOP regimen, has shown efficacy and safety in patients who are more than 80 years old. This study aimed to compare the area under the plasma concentration–time curves (AUCs) of vincristine (VCR), doxorubicin (DXR), and cycloph...
Autores principales: | Nakagawa, Junichi, Takahata, Takenori, Hyodo, Rui, Chen, Yu, Hasui, Kengo, Sasaki, Kota, Saito, Kensuke, Ueno, Kayo, Hosoi, Kazuhiro, Terui, Kazufumi, Sato, Atsushi, Niioka, Takenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803984/ https://www.ncbi.nlm.nih.gov/pubmed/33436910 http://dx.doi.org/10.1038/s41598-020-80706-2 |
Ejemplares similares
-
Impact of polymorphisms of pharmacokinetics‐related genes and the inflammatory response on the metabolism of voriconazole
por: Aiuchi, Naoya, et al.
Publicado: (2022) -
Enteral lorlatinib after alectinib as a treatment option in anaplastic lymphoma kinase‐positive non‐small cell lung cancer with triple problems: carcinomatous meningitis, poor performance status, and dysphagia—a case report
por: Sasaki, Kota, et al.
Publicado: (2021) -
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation
por: Tanaka, Hisashi, et al.
Publicado: (2021) -
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
por: Takahashi, Naoto, et al.
Publicado: (2012) -
Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers
por: Yokoyama, Satoshi, et al.
Publicado: (2023)